Research Using Fetal Tissue

Hello HuffPo! Some of you may know me from junkscience.com or healthnewsdigest.com. My main focus here will be on science, or what passes for science these days. Many people of good will are not aware that our government spends more than $400 billion per year on R &D. Regrettably, a substantial amount of that ends of being little more than a form of academic welfare, for research that has almost no chance of ever leading to anything practical, and in many cases does not even add to so-called "basic knowledge." By way of example (and I will have many more), let's take a look at a current hot topic: Research using fetal tissue. This is hardly a new phenomenon. Fetal tissue has been harvested for medical research for years. Even before abortion was legalized, other sources were tapped, and according to an article by AP science writer Malcolm Ritter, this practice dates back to the 1930s. Ritter, and many others, like to invoke the 1954 Nobel Prize for Physiology or Medicine. As Ritter puts it, "The 1954 Nobel Prize in medicine was awarded for work with fetal tissue that led to developing a vaccine against polio." Not so fast... According to the Nobel Foundation, that particular prize was awarded jointly to John Franklin Enders, Thomas Huckle Weller, and Frederick Chapman Robbins "for their discovery of the ability of poliomyelitis viruses to grow in cultures of various types of tissue." Indeed, many types of tissue were used besides human embryo...
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

A novel strategy of EGFR‑TKI combined chemotherapy in the treatment of human lung cancer with EGFR‑sensitive mutation. Oncol Rep. 2018 Jun 18;: Authors: Zhang L, Qi Y, Xing K, Qian S, Zhang P, Wu X Abstract The discovery of epidermal growth factor receptor (EGFR)‑sensitive mutations in non‑small cell lung cancer (NSCLC) and the successful clinical application of EGFR tyrosine kinase inhibitors (TKIs) have changed the regimen of lung cancer therapy from traditional cytotoxic chemotherapy to molecular‑targeted cancer therapy. However, the main limitation of EGFR‑TKI therapy is the hetero...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
Authors: Tamura H, Higa A, Hoshi H, Hiyama G, Takahashi N, Ryufuku M, Morisawa G, Yanagisawa Y, Ito E, Imai JI, Dobashi Y, Katahira K, Soeda S, Watanabe T, Fujimori K, Watanabe S, Takagi M Abstract Patient-derived tumor xenograft models represent a promising preclinical cancer model that better replicates disease, compared with traditional cell culture; however, their use is low-throughput and costly. To overcome this limitation, patient-derived tumor organoids (PDOs) were established from human lung, ovarian and uterine tumor tissues, among others, to accurately and efficiently recapitulate the tissue architecture...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
This study is aimed to investigate the association between EPHA3 expression and androgen receptor (AR) signaling and the potential mechanism. We determined mRNA and protein levels of EPHA3 and AR signaling‑related genes in the PCa cell line 22Rv1 by reverse transcription‑polymerase chain reaction (RT‑PCR) and western blotting, respectively. The EPHA3 mRNA and protein levels were both found to be elevated by dihydrotestosterone (DHT) hormone in a dose‑ and time‑dependent manner, as AR and prostate‑specific antigen (PSA) expression were increased. Similarly, EPHA3 protein levels were also increased in the PCa cel...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2. Oncol Rep. 2018 Jun 18;: Authors: Xu M, Jaing H, Wang H, Liu J, Liu B, Guo Z Abstract The mechanisms of malignant cell metastasis to secondary sites are complex and multifactorial. Studies have demonstrated that small integrin‑binding ligand N‑linked glycoproteins (SIBLINGs), particularly bone sialoprotein (BSP) and osteopontin (OPN), are involved in neoplastic growth and metastasis. SIBLINGs promote malignant cell invasion and metastasis by enhancing matrix metalloproteinase 2 (MMP‑2) and MMP‑9 ex...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
In conclusion, CAF‑derived HGF promotes angiogenesis, VM and mosaic vessel formation via PI3K/AKT and ERK1/2 signaling in gastric cancer and HGF may serve as a potential therapeutic target for cancer anti‑vascular treatment. PMID: 29917165 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
Authors: Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang P, Luo Y, Lin E, Hong X, Wu G Abstract Thyroid cancer is one of the most common malignant tumors of the endocrine system. Among all thyroid cancers, papillary thyroid carcinoma (PTC) is the most common type. The BRAF-activated non-coding RNA (BANCR) is a 693-bp nucleotide transcript which was first identified in melanoma. However, the role of BANCR in the development of thyroid cancer remains unclear. Therefore, the present study investigated the potential involvement of BANCR in the development of thyroid cancer in vitro using patient tissue samples and a pane...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
Authors: Sun Y, Jiang F, Pan Y, Chen X, Chen J, Wang Y, Zheng X, Zhang J Abstract X‑box‑binding protein 1 (XBP1) contributes to various types of cancer including breast, bladder cancer and esophageal squamous cell carcinoma. The aim of the study was to examine the metastatic role of XBP1 in oral squamous cell carcinoma (OSCC), and identify possible downstream molecules. Immunohistochemical staining was conducted on tissue microarrays comprising 96 OSCC cases to determine the expression level of XBP1 and analyze its association with metastasis, clinicopathological characteristics and survival prognosis. Compared...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
Authors: Zhang XH, Yang L, Liu XJ, Zhan Y, Pan YX, Wang XZ, Luo JM Abstract Suppressor of cytokine signaling‑1 (SOCS1) is a widely recognized tumor suppressor gene. Silencing of SOCS1 expression as a result of promoter methylation is associated with occurrence and development of solid tumors such as liver, cervical and pancreatic cancer. However, the association between SOCS1 gene methylation and acute myeloid leukemia (AML) has not been well explored. In the present study, we examined whether gene expression and methylation status of SOCS1 was altered in AML, and whether this was related to disease occurrence an...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
This month, the Pablove Foundation hung the photography of some of its young students on the walls of a Los Angeles gallery, giving viewers a look at how kids cope with cancer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Camille Moses, 58, is one of the nine percent of all people who survive past five years after a pancreatic cancer diagnosis. Now she is begging for more funding for research.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Academia | AIDS Vaccine | Bone Marrow Transplant | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Vaccines | Ebola | Ebola Vaccine | Environmental Health | Government | Grants | HIV AIDS | Kidney Transplant | Kidney Transplantation | Legislation | Lung Transplant | Men | Molecular Biology | Muscular Dystrophy | Nanotechnology | Neurology | Neuroscience | Parkinson's Disease | Physiology | Polio | Polio Vaccine | Reflex Sympathetic Dystrophy | Research | Science | Transplants | Urology & Nephrology | Vaccines | Veterinary Vaccinations | Websites | Yale